GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck KGaA (OTCPK:MKGAF) » Definitions » EBITDA Margin %

MKGAF (Merck KGaA) EBITDA Margin % : 30.02% (As of Sep. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Merck KGaA EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Merck KGaA's EBITDA for the three months ended in Sep. 2024 was $1,755 Mil. Merck KGaA's Revenue for the three months ended in Sep. 2024 was $5,845 Mil. Therefore, Merck KGaA's EBITDA margin for the quarter that ended in Sep. 2024 was 30.02%.


Merck KGaA EBITDA Margin % Historical Data

The historical data trend for Merck KGaA's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck KGaA EBITDA Margin % Chart

Merck KGaA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.72 28.26 30.29 29.47 27.08

Merck KGaA Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.15 23.22 27.87 28.72 30.02

Competitive Comparison of Merck KGaA's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Merck KGaA's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merck KGaA's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merck KGaA's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Merck KGaA's EBITDA Margin % falls into.



Merck KGaA EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Merck KGaA's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=6199.564/22893.13
=27.08 %

Merck KGaA's EBITDA Margin % for the quarter that ended in Sep. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=1754.717/5844.617
=30.02 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Merck KGaA  (OTCPK:MKGAF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Merck KGaA EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Merck KGaA's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Merck KGaA Business Description

Address
Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293
Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (44% of 2023 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (38%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (17%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

Merck KGaA Headlines

From GuruFocus

Q2 2023 Merck KGaA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Merck KGaA Capital Markets Day (Virtual) Transcript

By GuruFocus Research 02-14-2024

Q4 2022 Merck KGaA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Merck KGaA Capital Markets Day Transcript

By GuruFocus Research 02-14-2024

Merck KGaA at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 02-14-2024

Merck KGaA at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 02-14-2024

Merck KGaA Capital Markets Day Transcript

By GuruFocus Research 02-14-2024

Q3 2024 Merck KGaA Earnings Call Transcript

By GuruFocus News 11-15-2024

Q1 2023 Merck KGaA Earnings Call Transcript

By GuruFocus Research 02-14-2024